FDA Adverse Event
Injury
Summary report: N
LOFRIC DILACATH
MDR report key: 3181413
·
Received June 14, 2013
Report
- Report Number
- 3009632672-2013-00022
- Event Type
- Injury
- Date Received
- June 14, 2013
- Report Date
- September 8, 2011
- Manufacturer
- WELLSPECT HEALTHCARE
- Product Code
- FBX
- PMA / PMN Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- OTHER
Narratives
Additional Manufacturer Narrative · 1
THIS SUBMISSION IS BEING MADE AFTER AN ACQUISITION AND INTERNAL AUDIT OF WELLSPECT HEALTHCARE. SAMPLES RETURNED HAVE BEEN ANALYZED AND NO DEFECTS OR DEVIATIONS COULD BE FOUND. BASED UPON THE PRODUCT TESTING, THIS COMPLAINT COULD NOT BE CONFIRMED AS REPORTED.
Description of Event or Problem · 1
THE CUSTOMER THINKS THE COATING IS ROUGH AND HE HAD A BLEEDING AFTER CATHETERIZATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 270784 | LOFRIC DILACATH | URETHRAL DILATOR, FBX | FBX | WELLSPECT HEALTHCARE | 40618 | 86793 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |